Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Performer
12429.0000 105.00 (0.85%)
NSE May 09, 2025 15:31 PM
Volume: 41,049
 

12429.00
0.85%
KRChoksey
Neuland Labs (NEULANDLAB) is a small cap API and CDMO player, since 1984, promoted by Dr. Davuluri Rama Mohan Rao (Executive Chairman), who has a Postgraduate Diploma in Synthetic Drugs and Fine Chemicals Technology from IIT, Kharagpur and a PhD in organic chemistry from the University of Notre Dame, USA. It is being steered by his sons, Mr. Davuluri Sucheth Rao (Vice Chairman and CEO) and Mr. Davuluri Saharsh Rao (Vice Chairman and MD) who have been with the company since 2002 and 2007, respectively.
Number of MF schemes increased from 16 to 23 in Mar 2025 qtr.
More from Neuland Laboratories Ltd.
Recommended